At baseline, both control and inhibitor‐treated A431 lung cancer cells released DNA‐positive EVs of different sizes; however, the total number of DNA‐carrying EVs increased following exposure to the EGFR inhibitors, and also led to the emergence of another population of DNA‐positive nonvesicular particles. Here, EGFR is linked to lung cancer.